ArticleCureus2026
Management of Mobile Aortic Thrombus With Aspirin Monotherapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mobile aortic thrombus (MAT) is a rare clinical finding that can occur with or without underlying atherosclerotic or aneurysmal disease. Optimal management remains undefined due to limited data. We report the case of a 64-year-old woman with a history of sigmoid diverticulitis and methamphetamine use, incidentally found on computed tomography angiography (CTA) to have a proximal descending aortic mobile thrombus with associated splenic and right renal infarcts. Due to an elevated risk of gastrointestinal bleeding, anticoagulation was not recommended, and the patient was managed conservatively with aspirin 81mg daily and strict blood pressure control. Follow-up CTA at six months demonstrated complete thrombus resolution without recurrent embolic events. This case highlights the potential role of antiplatelet monotherapy in selected patients with MAT when anticoagulation or surgical intervention is contraindicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.